Nebraska Medicine-Village Pointe is a clinical research site located in Omaha, Nebraska, United States 68118.
Crixeo Clinical Trials Trust Score: 32/100 (FAILING). This profile has not yet been claimed by the site owner.
Nebraska Medicine-Village Pointe has participated in 120 clinical trials with 99 currently active.
Therapeutic areas: Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8.
Sponsors: National Cancer Institute (NCI), NRG Oncology, Seagen, a wholly owned subsidiary of Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Nebraska · View every site in Omaha
Trust Score: 32/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Nebraska Medicine-Village Pointe has a Crixeo Trust Score of 32/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Nebraska Medicine-Village Pointe has 120 clinical trials on record, with 99 currently active. Their work covers Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8.
Nebraska Medicine-Village Pointe has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.